Download PDF
Arthritis und Rheuma 2004; 24(03): 88-91
DOI: 10.1055/s-0037-1618462
Spätfolgen neurologischer Erkrankungen
Schattauer GmbH

Die Chemodenervation in der Behandlung neurologischer Spätbilder

Chemodenervation and the treatment of late sequelae in neurological disease
Brigitte Jann
1   Rehabilitationszentrum, Kinderspital Zürich
› Author Affiliations
Further Information

Publication History

Publication Date:
23 December 2017 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Dieser Artikel fasst die historische Entwicklung und die häufigsten praktischen Anwendungsmöglicheiten der Chemodenervation zusammen. Die beiden Substanzen Phenol und Botulinumtoxin werden einander gegenübergestellt und ihre klinische Indikation, Einschränkungen und Nebenwirkungen erläutert.

Summary

This article presents a brief historical overview of the development of chemodenervation, its clinical possibilities and common use. Phenol and Botulinum toxin and their clinical applications as well as limitations and side effects are discussed.

Schlüsselwörter

Chemodenervation - Phenol - Botulinumtoxin - Spastizität - muskulärer Hypertonus

Keywords

Chemodenervation - phenol - botulinum toxin - spasticity - muscular hypertonia
 

  • Literatur

  • 1 Bonica JL.. The Management of Pai. Philadelphia: Lea and Febiger; 1953
    Search in Google Scholar
  • 2 Dolly JO.. et al Insights into the Extended Duration of Neuroparalysis by Botulinum Neurotoxin A Relative to the Shorter-Acting Serotypes: Differences between Motor Nerve Terminals and Cultured Neuron. In Brin MF., Hallett M., Jankovic J.. Editors Scientific and therapeutic aspects of Botulinum Toxin.. Philadelphia: Lippincott Williams & Wilkins; 2002: 91-102.
    Search in Google Scholar
  • 3 Francisco GE., Boake C., Vaughn A.. Botulinum Toxin in Upper Limb Spasticity after Acquired Brain Injury. Am J Phys Med Rehabil 2002; 81: 355-63.
    CrossrefPubMedSearch in Google Scholar
  • 4 Glenn MB., White J.. The Practical Management of Spasticity in Children and Adults. Philadelphia: Lea and Febiger; 1990
  • 5 Hecht JS.. Subscapular Nerve Block in the Painful Hemiplegic Shoulder. Arch Phys Med Rehabil 1992; 73: 1036-9.
    PubMedSearch in Google Scholar
  • 6 Keenan MA.. et al Percutaneus phenol block of the musculocutaneous nerve to control elbow flexor spasticity. The Journal of Hand Surgery 1990; 15A: 340-5.
    Search in Google Scholar
  • 7 Khalili AA.. et al Management of spasticity by selective peripheral nerve block with dilute phenol solutions in clinical rehabilitation. Arch Phys Med Rehabil 1964; 45: 513-9.
    PubMedSearch in Google Scholar
  • 8 Molenaers G.. et al A multilevel approach to botulinum toxin type A treatment of the (ilio)psoas in spasticity in cerebral palsy. European Journal of Neurology 1999; 6 (Suppl. 04) Suppl S59-67.
    CrossrefSearch in Google Scholar
  • 9 Petrillo CR., Knoploch S.. Phenol block of the tibial nerve for spasticity: a long term follow-up study. Int Disabil Studies 1988; 10: 97-100.
    Search in Google Scholar
  • 10 Seidel PM.. et al Precise Localisation of the Motor Nerve Branches to the Hamstring Muscles: An Aid in the Conduct of Neurolytic Procedures. Arch Phys Med Rehabil 1996; 77: 1157-60.
    CrossrefPubMedSearch in Google Scholar
  • 11 Ward AB.. Botulinum toxin type A treatment of hip and thigh spasticity: a technique for injection of psoas major muscle. European Journal of Neurology 1999; 6 (Suppl. 04) suppl S91-3.
    CrossrefSearch in Google Scholar